Skip to content
Search

Latest Stories

Mahendra Patel spearheads historic partnership in Northern Ireland

Mahendra Patel spearheads historic partnership in Northern Ireland

The partnership aims to improve health outcomes and reduce disparities through collaborative research

The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with key health and social care agencies in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements.


Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region to partner with CfRE.

The partnership, involving the Health and Social Care Research and Development (HSC R&D) Division in Northern Ireland, the Department of Health Northern Ireland, and other key health and social care agencies, aims to improve health outcomes and reduce disparities through collaborative research.

Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents “a significant step forward in efforts to address health inequalities” in the region.

“By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities,” he said.

Professor Mahendra G Patel, Director of CfRE, emphasised the partnership's commitment to community engagement, stating: "At the heart of this ground-breaking partnership between Oxford University and Northern Ireland is a dedication to involving patients, the public, underserved communities, as well as health and care organisations and stakeholders in setting research priorities.”

He added: “We want to ensure that research outcomes are applicable, safe and beneficial to all, and that starts with listening to and engaging with the very people we serve, including those who are often disproportionately affected by poorer health and health outcomes.”

Laura Collins, Lived Experience Expert (Family Carer), and Public Involvement Enhancing Research (PIER) group member, HSC Research & Development Division, Public Health Agency, and a full-time family carer for the past 43 years, underscored the significance of research equity for patients and carers.

"As someone who has spent decades advocating for family carers and individuals with disabilities, I know firsthand how crucial it is for research to reflect the needs and experiences of all communities.

“The partnership's commitment to involving all in research is a vital step towards ensuring that everyone can benefit from advances in healthcare,” she said.

Professor Cathy Harrison, Chief Pharmaceutical Officer in Northern Ireland, noted that this initiative builds on the lessons learned and relationships forged during the COVID-19 pandemic.

She added that they are committed to developing new collaborative approaches that will ensure that research reaches and includes diverse populations, including those who have been “historically underrepresented” or “faced barriers to accessing research opportunities.”

Professor Ian Young, Chief Scientific Advisor at the Northern Ireland Department of Health, highlighted that this new partnership brings together various sectors in Northern Ireland, including health and social care, academia, industry, and the voluntary sector, to leverage collective strengths.

Dr. Janice Bailie, Assistant Director at HSC R&D Division, pointed out that this collaboration reflects their dedicated effort to incorporate the perspectives of diverse communities into their research framework and ensure inclusivity.

Professor Richard Hobbs, Pro-Vice Chancellor of the University of Oxford, noted that this partnership is not a one-time initiative, but rather “a long-term commitment to advancing research equity and improving health outcomes in Northern Ireland and beyond.”

“By building a strong foundation of collaboration and community engagement, we aim to create lasting change,” he said.

This initiative is part of CfRE's broader strategy to establish multiple hubs across the UK, to aimed at building a healthier and more inclusive future for all.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less